(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 3. Upregulation of NKX6.2 expression in Nkx6.1 mutant embryos.
Immunofluorescence detection of NKX6.1 with NGN3 (A), insulin (Ins) (B),
glucagon (Glc) (C) or amylase (Amy) (D) in pancreas from E14.5 (A) and E15.5
(B-D) embryos. NKX6.1 is expressed in a subset of NGN3+ cells (A),
in all insulin+ cells (B), and in very few glucagon+
cells (arrowhead in C). No co-expression of NKX6.1 and amylase is observed
(D). (E-P) Confocal images showing immunofluorescence staining for NKX6.2
together with various pancreatic markers in wild-type and
Nkx6.1-/- embryos. At E12.5, the number of
NKX6.2+ cells is increased in the pancreatic epithelium of
Nkx6.1 mutants (E,F). Upregulation of NKX6.2 in Nkx6.1
mutants is not seen in insulin+ (Ins) (arrowheads in G,H indicate
insulin+/NKX6.2- cells) or glucagon+ (Glc)
cells (arrowheads in K,L indicate glucagon+/NKX6.2-
cells). NGN3+ cells are NKX6.2- in wild type and
Nkx6.1 mutants (I,J). The ectopic Nkx6.2+ cells
in Nkx6.1 mutants do not produce amylase (Amy) (M,N). At E15.5, the
majority of ectopic NKX6.2-expressing cells co-express PDX1 (O,P). (Q)
Quantification of NKX6.2+ cells in wild-type and
Nkx6.1-/- embryos. The average number of
NKX6.2+ cells per section was determined by counting
immunofluorescence-labeled cells at E10.5, E12.5 and E15.5. Four independent
pancreata were evaluated for each genotype. The average number of cells are
shown as a % of wild type (arbitrarily set to 100%) ±s.e.m. Scale bar:
50 µm.